Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fidarestat is an aldose reductase inhibitor (IC50s: 26 nM, 33 μM, and 1.8 μM for aldose reductase, AKR1B10, and V301L AKR1B10, respectively). It has the potential to treat diabetic disease.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 約 35 days | ¥ 61,500 |
5 mg | 約 35 days | ¥ 273,000 |
10 mg | 約 35 days | ¥ 484,000 |
説明 | Fidarestat is an aldose reductase inhibitor (IC50s: 26 nM, 33 μM, and 1.8 μM for aldose reductase, AKR1B10, and V301L AKR1B10, respectively). It has the potential to treat diabetic disease. |
ターゲット&IC50 | Aldose reductase:26 nM, AKR1B10:33 μM, AKR1B10 (V301L):1.8 μM |
別名 | SNK 860 |
分子量 | 279.22 |
分子式 | C12H10FN3O4 |
CAS No. | 136087-85-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (895.35 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fidarestat 136087-85-9 Endocrinology/Hormones Metabolism Reductase SNK 860 SNK-860 SNK860 Inhibitor inhibitor inhibit